Table 4.

Bayesian estimated regression coefficients and 95% credible interval of the association of CVDs risk factors profiles and overall diet quality index in the Isfahan Cohort Study

		latent profiles of CVDs risk factors
		FPMS profile			DLCO profile			ILIS profile
		Coefficient	SD	95% credible interval	Coefficient	SD	95% credible interval	Coefficient	SD	95% credible interval
Diet quality index (DQI)	Model 1	0.59	0.12	(0.36, 0.84)	0.35	0.08	(0.20, 0.51)	0.56	0.11	(0.38, 0.79)
	Model 2	0.56	0.12	(0.32, 0.86)	0.41	0.07	(0.28, 0.54)	0.56	0.07	(0.42, 0.71)
	Model 3	0.54	0.12	(0.31, 0.78)	0.41	0.07	(0.27, 0.54)	0.57	0.07	(0.42, 0.71)
	Model 4	0.38	0.12	(0.14, 0.64)	0.17	0.06	(0.04, 0.29)	0.28	0.07	(0.15, 0.41)
	Model 5	0.26	0.12	(0.03, 0.51)	0.14	0.07	(0.01, 0.27)	0.24	0.07	(0.11, 0.38)

FPMS: Fit Pre Metabolic Syndrome; DLCO: DisLipoproteinemia Central Obese; ILIS: Impaired Laboratory Inflammatory State;

Model 1: unadjusted model

Model 2: adjusted for demographic variables (age, sex, education level, marital status and residency)

Model 3: adjusted for demographic variables and lifestyle-related variables (smoking status, physical activity and coping strategies)

Model 4: adjusted for demographic variables, lifestyle-related variables, and used medications (anti-dyslipidemia, anti-hypertensive, anti-diabetic medications)

Model 5: adjusted for demographic variables, lifestyle-related variables, used medications and family history of hyperlipidemia, hypertension, diabetes, myocardial infarction, and stroke